Anti-B3GNT5 aptamer SELEX Service(Cat#: CTApt-1670)

This is an aptamer development services to screening aptamers binds to the B3GNT5 with an affinity of 1nM~1μM.

Datasheet MSDS COA
Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target B3GNT5
Alternative Names UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 5; Lactosylceramide 1,3-N-Acetyl-Beta-D-Glucosaminyltransferase; Beta3Gn-T5; UDP-GlcNAc:Beta-Gal Beta-1,3-N-Acetylglucosaminyltransferase 5; Beta-1,3-N-Acetylglucosaminyltransferase 5; Lactotriaosylceramide Synthase; Lc(3)Cer Synthase; Beta-1,3-Gn-T5; Lc3 Synthase; B3GN-T5; BGnT-5; Beta 1,3 N-Acetyglucosaminyltransferase Lc3 Synthase; Beta-1,3-N-Acetylglucosaminyltransferase BGnT-5; EC 2.4.1.206; EC 2.4.1; B3GNT5
Gene ID 84002
UniProt ID Q9BYG0
Target Overview This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase family. This enzyme is a type II membrane protein. It exhibits strong activity to transfer GlcNAc to glycolipid substrates and is identified as the most likely candidate for lactotriaosylceramide synthase. This enzyme is essential for the expression of Lewis X epitopes on glycolipids.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry
×